ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer

Liao, Hua; Chang, Xiaodan; Gao, Lin; Ye, Cuiping; Qiao, Yujie; Xie, Lingyan; Lin, Jie; Cai, Shaoxi*; Dong, Hangming*南方医科大学; 5
Journal of Translational Medicine2023-11-17DOI: 10.1186/s12967-023-04365-3
7阅读
引用收藏
分享

摘要

Background The tumor microenvironment plays a key role in non-small cell lung cancer (NSCLC) development and also influences the effective response to immunotherapy. The pro-inflammatory factor interleukin-17A mediates important immune responses in the tumor microenvironment. In this study, the potential role and mechanisms of IL-17A in NSCLC were investigated. @@@ Methods We detected IL-17A by immunohistochemistry (IHC) in 39 NSCLC patients. Its expression was correlated with the programmed cell death-ligand1 (PD-L1). IL-17A knockdown and overexpression in A549 and SPC-A-1 cell models were constructed. The function of IL-17A was examined in vitro by wound healing, migration, invasion, plate colony formation and T cell killing assay. Western blot analysis, immunofluorescence assay and IHC were performed to investigate the regulation effects of IL-17A on autophagy in A549 and SPC-A-1. The effect of IL-17A on ROS/Nrf2/p62 signaling pathway was detected. Subcutaneous tumor models were established to examine the tumor-promoting effect of IL-17A in vivo and its effect on immunotherapy. @@@ Results We found a prevalent expression of IL-17A in NSCLC tumor tissues and it was positively correlated with PD-L1 expression (r = 0.6121, p < 0.0001). In vitro, IL-17A promotes lung cancer cell migration, invasion and colony formation ability. Moreover, IL-17A upregulated N-cadherin, Twist, and Snail, and downregulated E-cadherin in NSCLC cells. IL-17A enhanced cell survival in the T cell killing assay. Mechanistically, IL-17A induced ROS production and increased Nrf2 and p62 expression, thereby inhibiting autophagy and reducing PD-L1 degradation. In vivo experiments, anti-IL-17A monoclonal antibody alone slowed the growth of subcutaneous tumors in mice. When combined with anti-PD-L1 monoclonal antibody, tumor tissue expression of PD-L1 was reduced and the therapeutic effect was diminished. @@@ Conclusion We found that IL-17A promoted NSCLC progression and inhibited autophagy through the ROS/Nrf2/p62 pathway leading to increased PD-L1 expression in cancer cells. Modulation of IL-17A may affect the therapeutic efficacy of immunotherapy.

学科与关键词

关键词
Interleukin-17ANSCLCAutophagyPD-L1Immunotherapy
相关
加载中…
  • Distribution and Clinical Significance of IL-17A in Tumor-Infiltrating Lymphocytes of Non-Small Cell Lung Cancer Patients
    Xu, Rui; Ke, Xing; Shang, Wenwen; Liu, Shuna; Fu, Xin; Wang, Ting; Jin, ShuxianPATHOLOGY & ONCOLOGY RESEARCH, 2022, 28: 1610384.被引 10
  • Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancer
    Shen, Xiangfeng; Zhao, Yuan; Liu, Guolong; Zhou, Hong-Lan; Fan, Jingjing; Zhang, Lihong; Li, Yu-Lin; Wang, Yishu*; Liang, Jiyong*; Xu, Zhi-Xiang*Life Sciences, 2020, 256: 117923.被引 22
  • Role of Peripheral Blood T Helper 17 Cells in Non-Small Cell Lung Cancer of Different Clinical Stages, Pathological Types and Differentiation Degrees
    Fu, Kai; Wang, Xuefeng*; Li, Jingbo; Wang, JuClinical Laboratory, 2023, 69(10): 2047-2051.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Translational Medicine
发表日期
2023-11-17
卷期
第 21 卷, 第 1 期
页码
828
DOI
10.1186/s12967-023-04365-3
语言
ENGLISH
成果收录
SCIE
资助标注
Not applicable.

作者

  • L

    Liao, Hua (第一作者)

    southern med univ · 5

  • C

    Chang, Xiaodan

    southern med univ

查看全部 9 位作者收起作者
  • G

    Gao, Lin

    southern med univ

  • Y

    Ye, Cuiping

    southern med univ

  • Q

    Qiao, Yujie

    southern med univ

  • X

    Xie, Lingyan

    southern med univ

  • L

    Lin, Jie

    southern med univ

  • C

    Cai, Shaoxi (通讯)

    southern med univ

  • D

    Dong, Hangming (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417